In the first half of 2025, the company plans to present efficacy data on ABS-301 with similar R&D expenses to ABS-101. They are using the same manufacturer, WuXi, for ABS-201.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
